Press release
Global Homatropine Hydrobromide Market, Size, Share, Analysis Report & Forecast to 2026
The global homatropine hydrobromide market is expected to grow at a significant CAGR during the forecast period (2021-2027). Homatropine hydrobromide is an anticholinergic medication that causes mydriasis and cycloplegia, as well as other anticholinergic effects. Other effects of structurally similar atropine that might apply to homatropine include secretion inhibition, tachycardia, smooth muscle relaxation, and central neurological effects such as excitement.Homatropine hydrobromide is a competitive muscarinic receptor antagonist that replaces the acetyl group of acetylcholine with a bulky aromatic group. It's thought to work similarly to atropine, causing parasympatholytic effects. Homatropine inhibits the reaction of the iris sphincter muscle, causing the pupil to become unresponsive to light upon dilatation or mydriasis, via inhibiting muscarinic receptors and cholinergic signalling pathways. It also prevents cholinergic activation of the ciliary body's accommodating muscle.Free Sample Copy @ https://www.omrglobal.com/request-sample/homatropine-hydrobromide-market
Homatropine relaxes the muscles in the iris of the eye. The pupil dilates or expands when these muscles are relaxed. Ophthalmic homatropine is used to treat a condition known as uveitis. During an eye checkup, ophthalmic homatropine is frequently used to dilate the pupil or to relieve pressure inside the eye after surgery. This medication is used to treat some eye problems before and during eye tests (such as refraction), as well as before and during certain eye surgeries (e.g., uveitis). Homatropine hydrobromide acts via dilation of the pupil (dilating it).According to IOVS Arvo Journal, Age-related cataract (ARC) is still the most common cause of vision loss globally, particularly in China, which has one-fifth of the world's population. Surgery is now the sole effective therapy for cataracts, although it is still prohibitively expensive in impoverished nations. A cataract is a major socioeconomic burden all around the world. The overall cost of ARC in the United States, according to the US government, is $5 to $6 billion each year.
A Full Report of Global Homatropine Hydrobromide Market is Available at:
https://www.omrglobal.com/industry-reports/homatropine-hydrobromide-market
As the elderly population grows, so does the visual impairment caused by ARC and the resulting economical load. Therefore, the rising incidences of cataracts and other visual disorders requiring surgery in the geriatric population are expected to drive the market growth of the global Homatropine hydrobromide market.Furthermore, C2 Pharma (C2P), a Luxembourg-based phytochemical and chemical-pharmaceutical production and distribution company, is continuing to expand its API and botanical extracts product line. The authorization of Homatropine hydrobromide was the most recent contribution in 2020 that will propel the market growth.
Global Homatropine Hydrobromide Market – Segmentation
By Type
Injectable
Tablets
Drops
By Application
Ophthalmology
Global Homatropine Hydrobromide Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Centroflora
Hubei Biocause Pharmaceutical
Pioneer Agro Industries
Resonance Laboratories
Saurav Chemicals
Vital Laboratories.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/homatropine-hydrobromide-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Homatropine Hydrobromide Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2429011 • Views: …
More Releases from Orion Market Research
European Digital Signage Market | Business Growth, Development Factors, Current …
The European Digital Signage market is estimated to reach around $7.5 billion in 2025 as compared to $4.8 billion in 2018 at a CAGR of 7.0% over the forecast period. Europe has been significantly contributing to the global market, owing to the increasing expenditure in the electronics, automotive, and healthcare sectors by the European countries in the past few years. Europe is considered as one of the prominent electronics regions,…
Digital Signage Market | Business Growth, Development Factors, Current and Futur …
Digital signage market is anticipated to grow at a considerable CAGR of 7.9% during the forecast period. Canada contributes considerably to the growth of the digital signage market in North America. Canadian digital signage installation was propelled by the growing adoption of AI, machine learning, and extensive use of IP-based devices. The applications of digital signage can be seen across different sectors which include airports, hotels and restaurants, retail malls,…
Consumer Electronics Market | Business Growth, Development Factors, Current and …
The global consumer electronics industry is expected to register considerable growth over the forecast period 2019-2025. Surging demand for products such as televisions, smartphones, and wearable devices is one of the primary driving factors for the global consumer electronic market. Moreover, rising disposable income coupled with increasing adoption of smart devices, technology proliferation, development of semiconductor industry, and increasing penetration of internet of things (IoT) are further fueling the growth…
Italy Digital Signage Market | Business Growth, Development Factors, Current and …
Italy Digital Signage market is estimated to grow at a CAGR of 6.5% during the forecast period to reach $830 million in 2025 from $530 million in 2018. Italy Italy Digital Signage Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms to have constant observation of latest market…
More Releases for Homatropine
Global Homatropine Methylbromide Market, Size, Share, Analysis Report & Forecast …
The global homatropine methylbromide market is expected to grow at a significant CAGR during the forecast period (2021-2027). The drug homatropine methylbromide belongs to a class of drugs known as anti-muscarinic. Homatropine is used to treat ulcers in the duodenum and stomach, as well as intestinal issues. In the treatment of peptic ulcers, it can be used with antacids or other medications. It can also be used to prevent motion…
Homatropine Methylbromide Market to Eyewitness Stunning Growth by 2027 | Centrof …
This Homatropine Methylbromide market research report contains extensive industry statistics, such as level of inflation, market pattern, requirement, availability, and valuation record. It only provides industry data and does not include any content that is useful to a person's immediate surroundings. This market report contains the transactions as well as the transactions that occur while on the lookout. It includes all research materials related to overview, evolution, and demand, as…
Homatropine Hydrobromide Market is Booming Worldwide by Top Emerging Players: Ce …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Homatropine Hydrobromide Market Research Report 2020". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Homatropine Hydrobromide market. Players can use the accurate market facts and figures…
Global Homatropine Hydrobromide Market Research Report
This report studies the global Homatropine Hydrobromide market status and forecast, categorizes the global Homatropine Hydrobromide market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Centroflora Novel Laboratories Actavis Geographically, this report studies the top producers and consumers, focuses on product capacity,…
Global Homatropine Methylbromide Market Research Report
This report studies the global Homatropine Methylbromide market status and forecast, categorizes the global Homatropine Methylbromide market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Centroflora HUBEI BIOCAUSE PHARMACEUTICAL PIONEER AGRO INDUSTRIES RESONANCE LABORATORIES Saurav Chemicals VITAL LABORATORIES Alchem International BOC Sciences…
Global Homatropine Methylbromide Market to Grow at a Notable Rate during the For …
The immense presence of Homatropine Methylbromide in the ophthalmology industry is slowly pushing the global Homatropine Methylbromide market to new heights. To report further, Market Research Hub (MRH) has added a new report to its database titled “Global Homatropine Methylbromide Market Research Report 2017”. This research study includes market analysis and forecast details for various segments of the market. As per the report, it is estimated that the market for…
